PubRank
Search
About
Dietary Intervention in Type-2 Diabetes and Pre-Diabetes
Clinical Trial ID NCT02519309
PubWeight™ 0.00
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT02519309
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Prevalence and trends in obesity among US adults, 1999-2008.
JAMA
2010
50.58
2
Effects of intensive glucose lowering in type 2 diabetes.
N Engl J Med
2008
47.90
3
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
N Engl J Med
2008
38.76
4
Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine.
J Am Soc Echocardiogr
2008
7.91
5
Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study.
Circulation
1997
7.03
6
The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome.
Proc Natl Acad Sci U S A
2007
3.76
7
Prevalence of obesity among adults: United States, 2011-2012.
NCHS Data Brief
2013
3.75
8
Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.
Science
2012
3.52
9
Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006.
Diabetes Care
2010
3.37
10
Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors.
Obes Rev
2012
2.14
11
Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction.
Nutr Metab (Lond)
2005
1.59
12
Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet.
Lipids
2008
1.57
13
Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial.
Circulation
2011
1.37
14
Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome.
Prog Lipid Res
2008
1.28
15
The role of obesity and lifestyle behaviours in a productive workforce.
Occup Environ Med
2010
1.19
16
FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial.
Diabetes
2012
1.16
17
A low-carbohydrate, ketogenic diet to treat type 2 diabetes.
Nutr Metab (Lond)
2005
1.09
18
Low-carbohydrate diet in type 2 diabetes: stable improvement of bodyweight and glycemic control during 44 months follow-up.
Nutr Metab (Lond)
2008
1.09
19
Long term effects of ketogenic diet in obese subjects with high cholesterol level.
Mol Cell Biochem
2006
0.88
20
Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes.
Nutrition
2012
0.86
21
Nitrogen metabolism and insulin requirements in obese diabetic adults on a protein-sparing modified fast.
Diabetes
1976
0.86
22
Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat.
Nutr Metab (Lond)
2008
0.83
23
Adherence to a low-fat vs. low-carbohydrate diet differs by insulin resistance status.
Diabetes Obes Metab
2012
0.83
24
Effects of diet composition and ketosis on glycemia during very-low-energy-diet therapy in obese patients with non-insulin-dependent diabetes mellitus.
Am J Clin Nutr
1996
0.82
25
Tailoring dietary approaches for weight loss.
Int J Obes Suppl
2012
0.75
Next 100